Jynarque
Ended Awarded Last action
- Contract number
- 36C26123N0909
- Awardee
-
Otsuka America Pharmaceutical Inc. UEI QKABLBMA8FT9
- Awarding agency
-
Veterans Integrated Service Network 21
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $12,225
Award facts
- Contract value 100% obligated
- $12,224.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Rockville, MD 20850, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 21 (VISN 21), awarded a delivery order to Otsuka America Pharmaceutical Inc. for Jynarque (tolvaptan) on September 26, 2023, with a ceiling value of $12,224.60. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2023, was issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and did not utilize a set-aside designation. The product will be delivered to Potomac, Maryland, and represents part of the VA's broader pharmaceutical procurement strategy for specialty medications.
This delivery order is issued against a larger Blanket Purchase Agreement valued at $83.3 million that Otsuka America Pharmaceutical Inc. maintains with the VA's National Acquisition Center for Jynarque, effective through March 26, 2026. Jynarque is a specialized pharmaceutical used to treat autosomal dominant polycystic kidney disease and hyponatremia, reflecting the VA's commitment to providing advanced treatment options for veterans with complex medical conditions. The award demonstrates the established capability and relationship between Otsuka America Pharmaceutical Inc., a major pharmaceutical manufacturer headquartered in Rockville, Maryland, and the VA's Veterans Health Administration across multiple integrated service networks nationwide.
Quick answers
Who was awarded contract 36C26123N0909?
36C26123N0909 was awarded to Otsuka America Pharmaceutical Inc. by Veterans Integrated Service Network 21 (Veterans Health Administration) on September 26, 2023.
How much is contract 36C26123N0909 worth?
The government has obligated $12,225 on 36C26123N0909.
Is contract 36C26123N0909 an order under another contract?
Yes. 36C26123N0909 is a delivery order under 36F79720D0099, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26123N0909 competed?
The extent of competition for 36C26123N0909 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award